Genetically modified mice, Pb-Cre+/− Ptenfl/fl LSL-MYCN+/+, develop prostate tumours in 100% of offspring compared with littermates that lack MYCN expression (Pb-Cre+/− Ptenfl/fl LSL-MYCN−/−). This evidence concerns the gene MYCN and prostate neoplasm.